Adalimumab (Tumor necrosis factor-blocker) reduces the expression of glial fibrillary acidic protein immunoreactivity increased by exogenous tumor necrosis factor alpha in an organotypic culture of porcine neuroretina

1. Fernandez-Bueno, I.
2. Garcia-Gutierrez, M.T.
3. Srivastava, G.K.
4. Gayoso, M.J.
5. Gonzalo-Orden, J.M.
6. Pastor, J.C.